[HTML][HTML] Development of a COVID-19 vaccine effectiveness and safety assessment system in Japan: the VENUS study
H Fukuda, M Maeda, F Murata - Vaccine, 2023 - Elsevier
Background There are currently no COVID-19 vaccine assessment systems in Japan that
allow for the active surveillance of both vaccinated and unvaccinated persons. Herein, we …
allow for the active surveillance of both vaccinated and unvaccinated persons. Herein, we …
Sodium–glucose cotransporter 2 inhibitor use in early-phase acute coronary syndrome with severe heart failure
K Kanaoka, Y Iwanaga, M Nakai… - European Heart …, 2023 - academic.oup.com
Aims Sodium–glucose cotransporter 2 inhibitor (SGLT2i) improves clinical outcomes in
patients with heart failure (HF), but has limited evidence of SGLT2i use in early-phase acute …
patients with heart failure (HF), but has limited evidence of SGLT2i use in early-phase acute …
Clinical Efficacy of Beta-1 Selective Beta-Blockers Versus Propranolol in Patients With Thyroid Storm: A Retrospective Cohort Study
Y Matsuo, T Jo, H Watanabe, H Matsui… - Critical Care …, 2024 - journals.lww.com
OBJECTIVES: Thyroid storm is the most severe manifestation of thyrotoxicosis. Beta-
blockers are among the standard treatment regimens for this condition, with propranolol …
blockers are among the standard treatment regimens for this condition, with propranolol …
Prognostic Value of Objective Social Isolation and Loneliness in Older Patients With Heart Failure: Subanalysis of FRAGILE‐HF and Kitasato Cohort
H Saito, D Maeda, N Kagiyama… - Journal of the …, 2024 - Am Heart Assoc
Background Social factors encompass a broad spectrum of nonmedical factors, including
objective (social isolation [SI]) and perceived (loneliness) conditions. Although social factors …
objective (social isolation [SI]) and perceived (loneliness) conditions. Although social factors …
SGLT2 Inhibitors vs GLP-1 Receptor Agonists and Clinical Outcomes in Patients With Diabetes With/Without Atrial Fibrillation
YH Chan, TF Chao, SW Chen, HF Lee… - The Journal of …, 2024 - academic.oup.com
Context The coexistence of diabetes mellitus and atrial fibrillation (AF) is associated with
substantial risks of adverse cardiovascular events. Objective The relevant outcomes …
substantial risks of adverse cardiovascular events. Objective The relevant outcomes …
Association between use of transdermal tulobuterol and short-term outcomes in patients with stroke and underlying chronic obstructive pulmonary disease: A …
Y Matsuo, T Jo, K Makito, H Matsui, K Fushimi… - Medicine, 2023 - journals.lww.com
Transdermal tulobuterol, a long-acting beta agonist in a transdermal form, is available in
some countries, including Japan, Korea, and China. It may provide an alternative treatment …
some countries, including Japan, Korea, and China. It may provide an alternative treatment …
Comparative cardiovascular safety of romosozumab versus bisphosphonates in Japanese patients with osteoporosis A new-user, active comparator design with …
Importance Romosozumab, a novel anti-osteoporotic agent, confers marked improvement in
bone mineral density; however, its cardiovascular safety remains a concern. Objective To …
bone mineral density; however, its cardiovascular safety remains a concern. Objective To …